Antisense modulation of VEGF-C expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsHong Zhang, Kenneth W. Dobie
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of VEGF-C. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding VEGF-C. Methods of using these compounds for modulation of VEGF-C expression and for treatment of diseases associated with expression of VEGF-C are provided.
Claims20
A compound 8 to 80 nucleobases in length targeted to a nucleic acid molecule encoding VEGF-C, wherein said compound specifically hybridizes with said nucleic acid molecule encoding VEGF-C and inhibits the expression of VEGF-C.
A compound 8 to 80 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of a preferred target region on a nucleic acid molecule encoding VEGF-C.
A method of screening for an antisense compound, the method comprising the steps of:
- a. contacting a preferred target region of a nucleic acid molecule encoding VEGF-C with one or more candidate antisense compounds, said candidate antisense compounds comprising at least an 8-nucleobase portion which is complementary to said preferred target region, and
- b. selecting for one or more candidate antisense compounds which inhibit the expression of a nucleic acid molecule encoding VEGF-C.
Dependencies are inferred from the claim text.